Tyra Biosciences, Inc.
Biotech developing precision FGFR medicines for cancer and genetic disorders.
TYRA | US
Overview
Corporate Details
- ISIN(s):
- US90240B1061
- LEI:
- Country:
- United States of America
- Address:
- 2656 STATE STREET, 92008 CARLSBAD
- Website:
- https://tyra.bio/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines. The company leverages its proprietary drug discovery platform, SNÅP, to design therapies that target fibroblast growth factor receptor (FGFR) biology. Its primary objective is to overcome acquired resistance to existing treatments and address genetic conditions. A key program in its pipeline is TYRA-300, a selective FGFR3 inhibitor being evaluated in clinical studies for children with achondroplasia and for patients with advanced solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Tyra Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tyra Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tyra Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
